Topical calcineurin inhibitors (TCIs) are a type of treatment that alters your immune system. You can use TCIs for atopic eczema. These therapies are “topical,” which means you put them on your skin. ...
Pimecrolimus and tacrolimus, 2 topical calcineurin inhibitors for the treatment of atopic dermatitis (AD), were not shown to increase the risk of cancer based on moderate-certainty evidence from a ...
The panel examines the evolution of atopic dermatitis (AD) treatment beyond topical steroids and calcineurin inhibitors, while evaluating the safety and efficacy of a specific topical therapy in AD ...
A review published in JAAD discussed the off-label use of systemic tacrolimus and voclosporin in patients with various dermatologic conditions. Tacrolimus is approximately 100 times more potent than ...
Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Researchers showed with moderate certainty that topical calcineurin inhibitors did not ...
In a comprehensive pharmacovigilance analysis, topical calcineurin inhibitors (TCIs) were not associated with a statistically significant lymphoma safety signal in patients with atopic dermatitis when ...
Lifemine Therapeutics Inc. has identified serine/threonine-protein phosphatase 2B (PPP3CC; PP2Bγ; calcineurin) inhibitors reported to be useful for the treatment of coronavirus acute respiratory ...
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer This multicenter phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results